Ask AI
ProCE Banner Activity

A Practical Framework for Clinical Integration of ADCs Into Individualized Treatment Plans for Patients With NSCLC

Slideset

Download these slides to better understand current biomarker targets of antibody–drug conjugates (ADCs), including HER2, EGFR, and c-Met, for the management of NSCLC and properly integrate ADCs into individualized plans to guide and optimize treatment.

Released: May 28, 2025

Expiration: November 27, 2025

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.